N/A
Manufactured by Gland Pharma Limited
16,183 FDA adverse event reports analyzed
Last updated: 2026-04-14
MESNA INJECTION is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Gland Pharma Limited. The most commonly reported adverse reactions for MESNA INJECTION include FEBRILE NEUTROPENIA, PYREXIA, OFF LABEL USE, NEUTROPENIA, THROMBOCYTOPENIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MESNA INJECTION.
Out of 7,956 classified reports for MESNA INJECTION:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 16,183 FDA FAERS reports that mention MESNA INJECTION. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FEBRILE NEUTROPENIA, PYREXIA, OFF LABEL USE, NEUTROPENIA, THROMBOCYTOPENIA, ANAEMIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Gland Pharma Limited in connection with MESNA INJECTION. Always verify the specific product and NDC with your pharmacist.